Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.52 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.52 |
| ▸ | CXCR2 | P25025 | 3/20 | 0.48 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.42 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14002114 | 0.87 | PABPC1 (0.48) | PABPC1EIF4HCXCR2LMNASMN1; SMN2 | |
| SCHEMBL14028726 | 0.84 | PABPC1 (0.59) | PABPC1EIF4HCXCR2LMNASMN1; SMN2 | |
| SCHEMBL14577467 | 0.83 | MAPT (0.49) | PABPC1EIF4HCXCR2CXCR1LMNA | |
| SCHEMBL6565641 | 0.81 | CXCR2 (0.68) | CXCR2CXCR1LMNASMN1; SMN2KMT2A | |
| SCHEMBL14002111 | 0.74 | PABPC1 (0.57) | PABPC1EIF4HLMNASMN1; SMN2NPSR1 | |
| SCHEMBL12352217 | 0.73 | PABPC1 (0.55) | PABPC1EIF4HLMNASMN1; SMN2NPSR1 | |
| SCHEMBL14002120 | 0.73 | PABPC1 (0.40) | PABPC1EIF4HLMNASMN1; SMN2NPSR1 | |
| SCHEMBL13691695 | 0.73 | MAPT (0.43) | CXCR2CXCR1LMNASMN1; SMN2KMT2A | |
| SCHEMBL11085000 | 0.72 | MEN1 (0.56) | LMNAKMT2AMEN1MAPTMAPK1 | |
| SCHEMBL10957092 | 0.71 | CXCR2 (0.60) | CXCR2CXCR1LMNASMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7998665-B2 | Color intermediate motion picture film | EASTMAN KODAK COMPANY (US) | 2011-08-16 | — | — | US | disclosed |
| US-20100167218-A1 | COLOR INTERMEDIATE MOTION PICTURE FILM | EASTMAN KODAK COMPANY | 2010-07-01 | — | — | US | disclosed |
| US-20090325108-A1 | COLOR PHOTOGRAPHIC MATERIALS WITH MAGENTA MINIMUM DENSITY DYES | LASER PACIFIC MEDIA CORPORATION | 2009-12-31 | — | — | US | disclosed |
| US-7632632-B1 | Color photographic materials with magenta minimum density dyes | EASTMAN KODAK COMPANY (US) | 2009-12-15 | — | — | US | disclosed |
| US-7629112-B1 | Color photographic materials with yellow minimum density colorants | EASTMAN KODAK COMPANY (US) | 2009-12-08 | — | — | US | disclosed |
| US-20090297992-A1 | COLOR PHOTOGRAPHIC MATERIALS WITH YELLOW MINIMUM DENSITY COLORANTS | KODAK (NEAR EAST) INC. | 2009-12-03 | — | — | US | disclosed |
| US-20090233247-A1 | INFRARED DYE FOR SILVER HALIDE-BASED PHOTOGRAPHIC ELEMENTS | EASTMAN KODAK COMPANY | 2009-09-17 | — | — | US | disclosed |
| US-20090234131-A1 | INFRARED DYE FOR SILVER HALIDE-BASED PHOTOGRAPHIC ELEMENTS | EASTMAN KODAK COMPANY (US) | 2009-09-17 | — | — | US | disclosed |
| US-7175975-B2 | Photographic material with improved development inhibitor releases | EASTMAN KODAK COMPANY (US) | 2007-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090234131-A1 | INFRARED DYE FOR SILVER HALIDE-BASED PHOTOGRAPHIC ELEMENTS | IK, HTT, HYPK | PABPC1 1639/4885EIF4H 1921/4885CXCR2 3929/4885 |
| US-20090233247-A1 | INFRARED DYE FOR SILVER HALIDE-BASED PHOTOGRAPHIC ELEMENTS | IK, HYPK, HTT | PABPC1 1739/4885EIF4H 1677/4885CXCR2 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.